These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9520982)

  • 21. [Status and development of new clinical contrast media for MR diagnosis of liver diseases].
    Rummeny EJ; Peters PE
    Radiologe; 1992 May; 32(5):225-31. PubMed ID: 1635982
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood-pool MR contrast material for detection and characterization of focal hepatic lesions: initial clinical experience with ultrasmall superparamagnetic iron oxide (AMI-227).
    Saini S; Edelman RR; Sharma P; Li W; Mayo-Smith W; Slater GJ; Eisenberg PJ; Hahn PF
    AJR Am J Roentgenol; 1995 May; 164(5):1147-52. PubMed ID: 7717222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of hepatic metastasis: manganese- and ferucarbotran-enhanced MR imaging.
    Choi JY; Kim MJ; Kim JH; Kim SH; Ko HK; Lim JS; Oh YT; Chung JJ; Yoo HS; Lee JT; Kim KW
    Eur J Radiol; 2006 Oct; 60(1):84-90. PubMed ID: 16920315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of superparamagnetic iron oxide to imaging of hepatocellular carcinoma.
    Tanimoto A; Kuribayashi S
    Eur J Radiol; 2006 May; 58(2):200-16. PubMed ID: 16414230
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [MRT of the liver. Clinical significance of nonspecific and liver-specific MRT contrast agents].
    Ba-Ssalamah A; Happel B; Kettenbach J; Dirisamer A; Wrba F; Längle F; Schima W
    Radiologe; 2004 Dec; 44(12):1170-84. PubMed ID: 15551031
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contrast agents for MR imaging of the liver.
    Low RN
    J Magn Reson Imaging; 1997; 7(1):56-67. PubMed ID: 9039594
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatobiliary-specific MR contrast agents: role in imaging the liver and biliary tree.
    Seale MK; Catalano OA; Saini S; Hahn PF; Sahani DV
    Radiographics; 2009 Oct; 29(6):1725-48. PubMed ID: 19959518
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Focal nodular hyperplasia of the liver: serial MRI with Gd-DOTA, superparamagnetic iron oxide, and Gd-EOB-DTPA.
    Kacl GM; Hagspiel KD; Marincek B
    Abdom Imaging; 1997; 22(3):264-7. PubMed ID: 9107647
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Superparamagnetic iron particles. The clinical results in the MR diagnosis of liver metastases].
    Ham B; Reichel M; Vogl T; Taupitz M; Wolf KJ
    Rofo; 1994 Jan; 160(1):52-8. PubMed ID: 8305693
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MR enhancement of hepatoma by superparamagnetic iron oxide (SPIO) particles.
    Yamamoto H; Yamashita Y; Yoshimatsu S; Baba Y; Takahashi M
    J Comput Assist Tomogr; 1995; 19(4):665-7. PubMed ID: 7622710
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparison of mangafodipir trisodium- and ferucarbotran-enhanced MRI for detection and characterization of hepatic metastases in colorectal cancer patients.
    Kim HJ; Kim KW; Byun JH; Won HJ; Shin YM; Kim PN; Lee MS; Lee MG
    AJR Am J Roentgenol; 2006 Apr; 186(4):1059-66. PubMed ID: 16554579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Focal nodular hyperplasia of the liver: imaging findings with emphasis on the findings of superparamagnetic iron oxide-enhanced MR imaging].
    Han JK; Kim SH
    Korean J Hepatol; 2006 Mar; 12(1):116-9. PubMed ID: 16565614
    [No Abstract]   [Full Text] [Related]  

  • 33. [Magnetic resonance imaging of hepatic focal lesions: dynamic contrastographic evaluation with gadolinium versus reticulo-endothelial hepato-specific contrast media].
    Di Cesare E; Cariello G; Barile A; Sabatini M; Michelini O; Erriquez D; Masciocchi C
    Radiol Med; 2000 Oct; 100(4):245-50. PubMed ID: 11155451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Soluble-type hepatobiliary contrast agents for MR imaging.
    de Haën C; Gozzini L
    J Magn Reson Imaging; 1993; 3(1):179-86. PubMed ID: 8428085
    [No Abstract]   [Full Text] [Related]  

  • 35. Liver imaging with ferumoxides (Feridex): fundamentals, controversies, and practical aspects.
    Clément O; Siauve N; Cuénod CA; Frija G
    Top Magn Reson Imaging; 1998 Jun; 9(3):167-82. PubMed ID: 9621405
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New contrast agents for imaging the liver.
    Helmberger T; Semelka RC
    Magn Reson Imaging Clin N Am; 2001 Nov; 9(4):745-66, vi. PubMed ID: 11694436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Accumulation of iron oxide particles around liver metastases during MR imaging.
    Hahn PF; Stark DD; Ferrucci JT
    Gastrointest Radiol; 1992; 17(2):173-4. PubMed ID: 1551515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Basic physics of MR contrast agents and maximization of image contrast.
    Hendrick RE; Haacke EM
    J Magn Reson Imaging; 1993; 3(1):137-48. PubMed ID: 8428081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Asialoglycoprotein receptor function in benign liver disease: evaluation with MR imaging.
    Reimer P; Weissleder R; Lee AS; Buettner S; Wittenberg J; Brady TJ
    Radiology; 1991 Mar; 178(3):769-74. PubMed ID: 1994416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical evaluation of ultrasmall superparamagnetic iron oxide particles for liver imaging.
    Saini S; Edelman RR; Li W; Petersein J; Hahn PF
    Acad Radiol; 1996 Aug; 3 Suppl 2():S409-12. PubMed ID: 8796616
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.